BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 847 filers reported holding BAXTER INTL INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,096,532 | -22.1% | 55,552 | -6.0% | 0.01% | -25.0% |
| Q2 2023 | $2,692,596 | +6.6% | 59,100 | -5.1% | 0.01% | +14.3% |
| Q1 2023 | $2,525,428 | +10.2% | 62,264 | +38.5% | 0.01% | 0.0% |
| Q4 2022 | $2,292,223 | +114511.2% | 44,972 | +154975.9% | 0.01% | – |
| Q4 2019 | $2,000 | -100.0% | 29 | -100.0% | 0.00% | -100.0% |
| Q3 2016 | $4,399,000 | +17.3% | 92,418 | +11.4% | 0.06% | -3.5% |
| Q2 2016 | $3,750,000 | +22.3% | 82,939 | +11.2% | 0.06% | +14.0% |
| Q1 2016 | $3,065,000 | +54.2% | 74,609 | +43.2% | 0.05% | +51.5% |
| Q4 2015 | $1,988,000 | +139.2% | 52,109 | +106.1% | 0.03% | +135.7% |
| Q3 2015 | $831,000 | -93.7% | 25,288 | -85.9% | 0.01% | -93.9% |
| Q1 2014 | $13,162,000 | +7.1% | 178,883 | +1.2% | 0.23% | +11.7% |
| Q4 2013 | $12,289,000 | +7.6% | 176,686 | +1.6% | 0.21% | -3.7% |
| Q3 2013 | $11,425,000 | -6.4% | 173,919 | -1.3% | 0.21% | -13.4% |
| Q2 2013 | $12,211,000 | – | 176,277 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |